Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Net Income | 13.48M | 14.73M | 15.84M | 12.64M | 13.21M |
Total Depreciation and Amortization | 58.72M | 56.11M | 55.16M | 61.98M | 56.92M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -9.31M | -15.94M | -13.08M | 10.85M | 10.82M |
Change in Net Operating Assets | 1.23M | -1.32M | -6.52M | -11.18M | -20.16M |
Cash from Operations | 64.12M | 53.57M | 51.40M | 74.28M | 60.79M |
Capital Expenditure | -11.33M | -17.51M | -13.88M | -15.39M | -18.39M |
Sale of Property, Plant, and Equipment | 728.70K | 1.06M | 890.20K | 1.14M | 1.27M |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -328.60K | 214.50K | -1.90K | 1.40M | 929.00K |
Cash from Investing | -10.93M | -16.23M | -12.99M | -12.84M | -16.19M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -478.46M | -300.83M | -363.44M | -782.30M | -789.60M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -328.35M | -279.68M | -270.40M | -310.57M | -309.40M |
Cash from Financing | -47.51M | -34.03M | -35.28M | -60.12M | -57.67M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 5.69M | 3.30M | 3.12M | 1.32M | -13.07M |